Anticancer candidate substance RX-0201 likely to be commercialized in 2007
Under the agreement, Rexgene Biotech will offer an initial clinical expenditure of $1.5 million to Re...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
